BioMimetic Therapeutics, Inc. (NASDAQ:BMTI) announced that the Company plans to release its financial results for the three and twelve months ended December 31, 2009, on Thursday, March 11, 2010 after the close of market. The Company will host a conference call and audio webcast to discuss its fourth quarter and year-end financial results, product development programs and business activities at 8:30 a.m. EST Friday, March, 12, 2010.

Related posts

• Hi-Tech Pharmacal to Release Third Quarter Earnings and Hold Conference Call on March 11, 2010 (0)
• GTC Biotherapeutics to Host Fourth Quarter and Year End 2009 Earnings Call and Webcast on Friday, March 12, 2010 (0)
• NPS Pharmaceuticals to Report 2009 Financial Results (0)
• ACADIA Pharmaceuticals to Announce Fourth Quarter and Full Year 2009 Financial Results on March 9, 2010 (0)
• Alliance HealthCare Services Schedules Conference Call and Webcast to Review Fourth Quarter and Full Year 2009 Financial Results (0)

Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) announced that the Company will release results for its third quarter of Fiscal Year 2010 ended January 31, 2010, prior to the market opening on Thursday, March 11, 2010 and will hold a conference call to discuss its financial results at 10 a.m. Eastern Time.

Related posts

• BioMimetic Therapeutics to Report 2009 Fourth Quarter and Year-End Financial Results on March 11 (0)
• GTC Biotherapeutics to Host Fourth Quarter and Year End 2009 Earnings Call and Webcast on Friday, March 12, 2010 (0)
• NPS Pharmaceuticals to Report 2009 Financial Results (0)
• ACADIA Pharmaceuticals to Announce Fourth Quarter and Full Year 2009 Financial Results on March 9, 2010 (0)
• Alliance HealthCare Services Schedules Conference Call and Webcast to Review Fourth Quarter and Full Year 2009 Financial Results (0)

GTC Biotherapeutics, Inc. (Nasdaq: GTCB) (“GTC”) announced that its financial results for the fourth quarter and year end 2009 will be released on Friday, March 12, 2010 followed by a webcast conference call starting at 10:00 a.m. Eastern Time.

Related posts

• BioMimetic Therapeutics to Report 2009 Fourth Quarter and Year-End Financial Results on March 11 (0)
• Hi-Tech Pharmacal to Release Third Quarter Earnings and Hold Conference Call on March 11, 2010 (0)
• NPS Pharmaceuticals to Report 2009 Financial Results (0)
• ACADIA Pharmaceuticals to Announce Fourth Quarter and Full Year 2009 Financial Results on March 9, 2010 (0)
• Alliance HealthCare Services Schedules Conference Call and Webcast to Review Fourth Quarter and Full Year 2009 Financial Results (0)

* 2009 record revenues of $234.8 million
* 2009 net income of $31.1 million, or $1.02 per share, representing eighth consecutive year of profitability
* 2009 cash and accounts receivable balance of $157.8 million, including $102.9 million of cash and $54.9 million of accounts receivable
* 2010 forecast anticipates total revenues of $235 to $255 million and net income of $20 to $30 million

Emergent BioSolutions Inc. (NYSE: EBS) announced its financial results for the full year ended December 31, 2009.
…..Click here to read more

Related posts

• Natus Medical Announces 2009 Fourth Quarter and Full Year Financial Results (0)
• CPEX Pharmaceuticals Reports 2009 Fourth-Quarter and Year-End Financial Results (0)
• Human Genome Sciences Announces Fourth-Quarter and Full-Year 2009 Financial Results and Key Developments (0)
• AMAG Pharmaceuticals Announces Fourth Quarter and Year End 2009 Financial Results (0)
• Alnylam Pharmaceuticals Reports Fourth Quarter and 2009 Financial Results (0)

Natus Medical Incorporated (Nasdaq:BABY) announced financial results for the fourth quarter and full year ended December 31, 2009.

For the fourth quarter ended December 31, 2009, Natus reported revenue of $51.6 million, compared to $43.4 million reported in the comparable quarter of the previous year. Net income was $4.3 million, or $0.15 per diluted share, for the fourth quarter of 2009, compared with net income of $6.3 million, or $0.22 per diluted share, for the fourth quarter of 2008. …..Click here to read more

Related posts

• Emergent BioSolutions Reports Financial Results for Full Year 2009 (0)
• CPEX Pharmaceuticals Reports 2009 Fourth-Quarter and Year-End Financial Results (0)
• Human Genome Sciences Announces Fourth-Quarter and Full-Year 2009 Financial Results and Key Developments (0)
• AMAG Pharmaceuticals Announces Fourth Quarter and Year End 2009 Financial Results (0)
• Alnylam Pharmaceuticals Reports Fourth Quarter and 2009 Financial Results (0)

BioReference Laboratories, Inc. (NASDAQ: BRLI) (Numbers in Thousands Except Per Share Data or where otherwise noted) released its first quarter, fiscal year 2010 earnings for the three months ending January 31. The Company had net revenues for the quarter of $99,261, an increase of 31% over the $75,735 of net revenues recorded in the first quarter …..Click here to read more

Related posts

• IMS Health Announces 2009 Fourth-Quarter and Full-Year Results (0)
• MEDNAX Reports GAAP EPS of $1.07 for 2009 Fourth Quarter (0)
• Health Care REIT, Inc. Announces Gross Investments of $716.6 Million for 2009 (0)
• OSI Pharmaceuticals Updates Preliminary Revenue & Re-affirms Adjusted Earnings Growth Rate Guidance for 2010 (0)
• Bio-Reference Laboratories, Inc. Announces Record Revenues and Earnings for Fourth Quarter and Fiscal Year (0)

NPS Pharmaceuticals, Inc. (Nasdaq: NPSP) announced that it will report its 2009 financial results on Thursday, March 11, 2010 at approximately 4:30 p.m. ET. The press release will be followed by a conference call and webcast at 5:00 p.m. ET.

Related posts

• BioMimetic Therapeutics to Report 2009 Fourth Quarter and Year-End Financial Results on March 11 (0)
• Hi-Tech Pharmacal to Release Third Quarter Earnings and Hold Conference Call on March 11, 2010 (0)
• GTC Biotherapeutics to Host Fourth Quarter and Year End 2009 Earnings Call and Webcast on Friday, March 12, 2010 (0)
• ACADIA Pharmaceuticals to Announce Fourth Quarter and Full Year 2009 Financial Results on March 9, 2010 (0)
• Alliance HealthCare Services Schedules Conference Call and Webcast to Review Fourth Quarter and Full Year 2009 Financial Results (0)

POZEN Inc. (NASDAQ:POZN), announced results for the fourth quarter and year ended December 31, 2009.

Fourth Quarter Results

POZEN reported a net loss of $(5.8) million, or $(0.19) per share on a diluted basis, for the fourth quarter of 2009, compared to net loss of $(4.1) million, or $(0.14) per share on a diluted basis, for the fourth quarter of 2008. …..Click here to read more

Related posts

• HealthSpring, Inc. Reports 2009 Fourth Quarter and Full Year Results and Provides Guidance for 2010 (0)
• Healthways to Issue Third Quarter 2009 Earnings Release and Host Conference Call after Market Close on October 22 (0)
• Hi-Tech Pharmacal to Release First Quarter Earnings and Hold Conference Call on September 9, 2009 (0)
• Peplin Results for the Financial Year Ended 30 June 2009 (0)
• Urologix Reports Fiscal 2009 Results Including Sequential Growth in Fourth Quarter Fiscal Year 2009 Revenue (0)

CPEX Pharmaceuticals, Inc. (NASDAQ: CPEX) reported financial results for the fourth quarter and year ended December 31, 2009. For the quarter CPEX reported revenues of $5.2 million and a net loss of $498,000. For the year CPEX reported revenues of $18.7 million and a net loss of $3.0 million.

Operating expenses for the year ended December 31, 2008 include a $1.2 million non-cash charge resulting from the modification of equity awards and $2.5 million of expenses related to the spin-off from Bentley Pharmaceuticals on June 30, 2008. …..Click here to read more

Related posts

• Emergent BioSolutions Reports Financial Results for Full Year 2009 (0)
• Natus Medical Announces 2009 Fourth Quarter and Full Year Financial Results (0)
• Human Genome Sciences Announces Fourth-Quarter and Full-Year 2009 Financial Results and Key Developments (0)
• AMAG Pharmaceuticals Announces Fourth Quarter and Year End 2009 Financial Results (0)
• Alnylam Pharmaceuticals Reports Fourth Quarter and 2009 Financial Results (0)

Nile Therapeutics, Inc. (NASDAQ:NLTX), a biopharmaceutical company in the development of novel therapeutics for heart failure patients, announced its fourth quarter and full year financial results for 2009. The company will host a conference call and live webcast to discuss these financial results and provide an update on each of its development programs at 8:30 a.m. EST on March 5, 2010. …..Click here to read more